Surgical management of multidrug-resistant tuberculosis

  • Susumu Sasano
  • Hiroshi Yamamoto
  • Tokuro Otsuka
  • Akria Fujita
  • Takamasa Onuki
  • Sumio Nitta
Article
  • 24 Downloads

Abstract

We report surgical resections in 3 patients with active multidrug-resistant tuberculosis. All cases involved strains of Mycobacterium tuberculosis resistant to at least isoniazid and rifampin and patients who were poor candidates for medical therapy alone. We conducted pulmonary resections (partial resection in case I, lobectomy in case 2, and segmentectomy in case 3). The optimum multiple-drug regimen, based on drug susceptibility studies, was used preoperatively and postoperatively. In all cases, sputum smears and cultures yielded negative results postoperatively, and continue to be negative for Mycobacterium tuberculosis to date. It is recomended that, if localized disease is present and medical treatment is likely to fail, pulmonary resection be conducted for multidrug-resistant Mycobacterium tuberculosis.

Key words

pulmonary tuberculosis multidrug-resistant tuberculosis pulmonary resection surgery 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328: 527–32.PubMedCrossRefGoogle Scholar
  2. 2.
    Pomerantz M, Brown JM. Surgery in the treatment of multidrug-resistant tuberculosis. Clin Chest Med 1997; 18: 123–30.PubMedCrossRefGoogle Scholar
  3. 3.
    Frieden TR, Sterling T, Pablog-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Park MM, Davis AL, Schluger NW, Cohen H, Rom WN. Outcome of MDR-TB patients, 1983–1993: prolonged survival with appropriate therapy. Am J Respir Crit Care Med 1996; 153: 317–24.PubMedCrossRefGoogle Scholar
  5. 5.
    Turett GS, Telzak EE, Torian LV, Blum S, Alland D, Weisfuse I, et al. Improved outcomes for patients with multidrug-resistant tuberculosis. Clin Infect Dis 1995; 21: 1238–44.PubMedCrossRefGoogle Scholar
  6. 6.
    Telzak EE, Sepkowitz K, Alpert P, Mannheimer S, Medard F, El-Sadr W, et al. Multidrug-resistant tuberculosis in patients without HIV infection. N Engl J Med 1995; 333: 907–11.PubMedCrossRefGoogle Scholar
  7. 7.
    Moore M, Onorato IM, McCray E, Castro KG. Trends in drug-resistant tuberculosis in the United States, 1993–1996. JAMA 1997; 278: 833–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Freixinet J. Surgical indications for treatment of pulmonary tuberculosis. World J Surg 1997; 21: 475–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Pomerantz M, Madsen L, Goble M, Iseman M. Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections. Ann Thorac Surg 1991; 52: 1108–12.PubMedCrossRefGoogle Scholar
  10. 10.
    Sung SW, Kang CH, Kim YT, Han SK, Shim YS, Kim JH. Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis. Eur J Cardiothorac Surg 1999; 16: 187–93.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Association for Thoracic Surgery 2001

Authors and Affiliations

  • Susumu Sasano
    • 3
  • Hiroshi Yamamoto
    • 1
  • Tokuro Otsuka
    • 1
  • Akria Fujita
    • 2
  • Takamasa Onuki
    • 3
  • Sumio Nitta
    • 3
  1. 1.Department of Chest SurgeryTokyo Metropolitan Fuchu HospitalTokyoJapan
  2. 2.Respiratory MedicineTokyo Metropolitan Fuchu HospitalTokyoJapan
  3. 3.Department of Surgery ITokyo Women's Medical UniversityTokyoJapan

Personalised recommendations